Details van artikel 191 van 418 gevonden artikelen
P-282 JAVELIN Gastric 300: Phase 3 trial of avelumab (anti-PD-L1 antibody) + best supportive care (BSC) vs BSC ± chemotherapy as third-line treatment for advanced gastric or gastroesophageal junction cancer
Titel:
P-282 JAVELIN Gastric 300: Phase 3 trial of avelumab (anti-PD-L1 antibody) + best supportive care (BSC) vs BSC ± chemotherapy as third-line treatment for advanced gastric or gastroesophageal junction cancer
Auteur:
Eric, Van Cutsem Lucjan, Wyrwicz Keun-Wook, Lee Fortunato, Ciardiello Rosine, Guimbaud Julien, Taieb Jayne, Gurtler Narikazu, Boku Huiling, Xiong Jenny, Zhang Jean-Marie, Cuillerot Yung-Jue, Bang
Verschenen in:
Annals of oncology
Paginering:
Jaargang 27 () nr. S2 pagina's ii82
Jaar:
2016
Inhoud:
Uitgever:
European Society for Medical Oncology
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 191 van 418 gevonden artikelen